Document is current

Any future updates will be listed below

Long-Term Safety and Efficacy of Teneligliptin in Elderly Patients with Type 2 Diabetes: Subgroup Analysis of a 3-Year Post-Marketing Surveillance in Japan

Crossref DOI link: https://doi.org/10.1007/s12325-020-01306-0

Published Online: 2020-04-22

Published Print: 2020-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark